115450 — HLB Therapeutics Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩643bn
- KR₩653bn
- KR₩55bn
Annual cashflow statement for HLB Therapeutics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17,401 | -17,764 | -12,104 | -3,079 | -23,460 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 8,369 | 7,140 | 3,800 | -7,322 | 18,031 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3,320 | -2,345 | -2,170 | 5,249 | -1,376 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11,651 | -11,268 | -8,809 | 3,327 | 1,288 |
| Capital Expenditures | -8,070 | -3,933 | -5,588 | -5,760 | -8,736 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -9,511 | 18,286 | -36,343 | -14,400 | -26,722 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -17,580 | 14,353 | -41,930 | -20,160 | -35,457 |
| Financing Cash Flow Items | — | — | -7.08 | -14.6 | -15.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -32.4 | 82,854 | -3,318 | -5,281 | 28,394 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -29,268 | 85,943 | -54,052 | -22,112 | -5,775 |